Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Memorial Sloan Kettering Cancer Center
P

Key Lymphoma Updates From ASH

By Memorial Sloan Kettering Cancer Center FEATURING Pallawi Torka
By Memorial Sloan Kettering Cancer Center FEATURING Pallawi Torka
410 views
May 2, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

09:50
Incyte

Managing Chronic GVHD Master Class Series: Best Practices at 100 Day…

Feat. C. Cutler

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Lymphoma
11:46

Low Dose TBI Improves CD19 CAR-T Expansion, Persistence, and Traffic…

Memorial Sloan Kettering Cancer Center

M. Alhomoud

37 views
11:46

Low Dose TBI Improves CD19 CAR-T Expansion, Persistence, and Traffic…

Memorial Sloan Kettering Cancer Center

M. Alhomoud

37 views
10:00

ASH 2024 Insights: Pembro Maintenance instead of ASCT for Pts With R…

Memorial Sloan Kettering Cancer Center

A. Moskowitz

217 views
14:56

ASH 2024 Insights: POLARIX 5yr Update - Pola-R-CHP vs. R-CHOP in 1L …

2024 ASH Annual Meeting Insights Hub

G. Salles

228 views
18:24

Key Lymphoma Updates From ASH

Memorial Sloan Kettering Cancer Center

P. Torka

410 views
16:05

SOHO 2023: What Is High Risk MCL and How Should We Treat It

SOHO 2023 Eleventh Annual Meeting

A. Kumar

194 views
21:58

The Evolving 1L DLBCL Landscape: POLARIX, Novel Agents and Future Di…

MedNews Week

M. Matasar

290 views
24:57

Current Management of Newly Diagnosed DLBCL

MedNews Week

M. Matasar

43 views
18:10

2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Features …

SOHO Brazil 2023

A. Moskowitz

88 views
38:55

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…

Indy Hematology Review

G. Salles

165 views
07:46

ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…

ASCO 2022 Conference Coverage

M. Matasar

79 views
05:16

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…

ASCO 2022 Conference Coverage

C. Lee Batlevi

66 views
34

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…

ASCO 2022 Conference Coverage

C. Lee Batlevi

20 views
12:32

SOHO 2021: The Next Wave of Novel Agents in Aggressive B-Cell Lympho…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

G. Salles

23 views
10:28

MSKCC 2021 Update on Therapeutic Advances in T-Cell Lymphoma: Subtyp…

i3 Health

S. Horwitz

146 views
24:05
SOHO Highlights: State of the Art and Next Questions

SOHO Highlights on Non-Bulky cHL: Can We Treat Early Disease With Sh…

Feat. D. Straus
11:39

Early Stage cHL Management: Bulky vs. Non-bulky Disease, Better Chem…

SOHO Highlights: State of the Art and Next Questions

D. Straus

174 views
15:22

2020 SOHO Update on R/R PTCL: Is There a Single Paradigm Overall? Ca…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

S. Horwitz

113 views
21:36

2020 SOHO Highlights on Newly Diagnosed HL: Is ABVD Chemo Regimen Be…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Straus

127 views
09:59

2020 SOHO Updates on R/R cHL: Can We Improve Chemo With ADCs and CPI…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Straus

58 views
11:13

2020 SOHO Update on DLBCL: CAR-T vs. autoHCT for Early Relapsed Dise…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

S. Giralt

28 views
07:09

Next Questions in DLBCL: New Genetic Classification Based Selection …

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Younes

66 views
15:47

Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the …

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Kumar

24 views
15:41

PI3Ki's in Indolent Lymphoma: Overview of Approved Drugs, Trial Base…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Zelenetz

68 views
15:30

Marginal Gastric Zone Lymphoma: The Role of Radiation Therapy

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

J. Yahalom

27 views
28:25

Does RCHOP Stay the Standard of Care After 6 Cycles in Advanced/R DL…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Younes

293 views
13:26

The Role of Venetoclax in DLBCL: Efficacy and Safety Results from th…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Zelenetz

92 views
11:13

Treating Elderly Patients with Hodgkin Lymphoma - How Much Bleomycin…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Moskowitz

185 views
23:38

Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokin…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. Santomasso

34 views